Results 221 to 230 of about 703,096 (358)

Drug Utilization, Dosing, and Costs After Implementation of Intravenous Acetaminophen Guidelines for Pediatric Patients

, 2014
Nicholas M. Fusco, Kristine A. Parbuoni, Jill Morgan   +2 more
openalex   +2 more sources

EVALUATION OF DRUG UTILIZATION PATTERN OF PATIENTS WITH ALCOHOLIC LIVER DISEASE IN JAYANAGAR GENERAL HOSPITAL

, 2020
Dr Priyanka N Harshith Kumar S
openalex   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Drug Utilization and Potentially Inappropriate Prescriptions Assessment Among Discharged Pediatric Patients in a Tertiary Care Hospital. [PDF]

Hosp Pharm
Maratha Muthu M, Balan S, Salim SS, Mohamad Idris EM, Nor Azmi AS.   +4 more
europepmc   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Off‑label and unapproved pediatric drug utilization: A meta‑analysis. [PDF]

Exp Ther Med
Yuan X, Gao J, Yang L, Tan Y, Bajinka O.
europepmc   +1 more source

We have the Tools to End HIV: Benefits, Barriers, and Solutions to Expanded Utilization of Pre-exposure Prophylaxis (PrEP) in the US Deep South [PDF]

, 2016
Ervin, Jason, McAllaster, Carolyn, Tikare, Allison Weller   +2 more
core   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Intranasal corticosteroid users in The Netherlands: A drug utilization study. [PDF]

J Allergy Clin Immunol Glob
Rollema C, Van Roon EN, Schuiling-Veninga NCCM, Bos JHJ, De Vries TW.   +4 more
europepmc   +1 more source

Utilization of Drug Information Resources in a Large Academic Institution: A Quality Improvement Study

Zeba Saiyad, Jacqueline Wasynczuk, Jennifer Phillips   +2 more
openalex   +1 more source